Israel aims to cement its legacy as a medical marijuana research hub with the Hebrew University of Jerusalem’s launch of the Multidisciplinary Center on Cannabinoid Research.
The newfound center plans to be a worldwide hub for cannabis research in the study of cannabinoids, endocannabinoids, and medical marijuana. The program will center its studies around ailments like “cancer, pain, inflammation and stress management” along with cannabis’ relationship to “immunity, metabolism, drug delivery, pharmaceutical chemistry, neuroscience and plant science and genetics.”
The program is helmed by its director Joseph Tam, who told The Jerusalem Post that “We feel incredibly fortunate to team up with a vast number of scientists working together on this expanding field of medicine with the significant potential to discover new therapies based on cannabinoids.”
In an email response to Marijuana.com, Tam added that:
The establishment of the Center that coordinates the research activities of multiple research laboratories at the Hebrew University into interdisciplinary networks, and fosters collaborations between its participating laboratories and well-established…